Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2003-11-24
2009-02-17
Helms, Larry R. (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C514S002600, C435S004000, C435S007230
Reexamination Certificate
active
07491394
ABSTRACT:
Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The invention also relates to methods for identifying active agents useful in treating conditions related to cell death or uncontrolled growth. The present inventors have found that different microorganisms produce different cytotoxic factor(s) having anticancer activity. The substantially pure cytotoxic factors can be used in a method of treating an infectious disease or a cancer.
REFERENCES:
patent: 5681810 (1997-10-01), Villemez et al.
patent: 5789389 (1998-08-01), Tarasewicz
patent: 5972899 (1999-10-01), Zychlinsky et al.
patent: 7084105 (2006-08-01), Chakrabarty et al.
patent: 2002/0110872 (2002-08-01), Chakrabarty et al.
patent: 2006/0040269 (2006-02-01), Chakrabarty et al.
patent: 2006/0149037 (2006-07-01), Chakrabarty et al.
patent: 2006/0251639 (2006-11-01), Chakrabarty et al.
patent: 2006/0251669 (2006-11-01), Chakrabarty et al.
patent: 2006/0292136 (2006-12-01), Chakrabarty et al.
patent: 2004/266632 (2005-03-01), None
patent: P10413574 (2006-10-01), None
patent: 2436224 (2002-10-01), None
patent: 2535581 (2005-03-01), None
patent: 1863545 (2006-11-01), None
patent: 1411963 (2004-04-01), None
patent: 1653990 (2006-05-01), None
patent: 2006/009835 (2006-09-01), None
patent: 2006/1168 (2006-05-01), None
patent: WO- 02/076380 (2002-10-01), None
patent: WO-2005/018662 (2005-03-01), None
patent: WO- 2006/088508 (2006-08-01), None
patent: WO-2006/127477 (2006-11-01), None
patent: WO- 2006/127514 (2006-11-01), None
patent: WO- 2007/012004 (2007-01-01), None
Mathews and Van Holde, Biochemistry, 1996, pp. 165-171.
W. Burgess,* AShaheen, et al., Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue.The Journal of Cell Biology. Vo. 111, 1990, 2129-2138.
Schwartz et al., Proc Natl Acad Sci USA, vol. 84, p. 6408-6411, 1987.
Lin et al Biochemistry USA, vol. 14, p. 1559-1563, 1975.
Zaborina et al., (Microbiology, vol. 146, p. 2521-2530, Oct. 2000.
Freshney et al., Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer et al., Bio/Technology, vol. 12, p. 320, 1994.
Gura Science, vol. 278, p. 1041-1042, 1997.
Zaborina et al., “Secretion of ATP-utilizing enzymes, nucleoside diphosphate kinase and ATPase, by MycobacteriumbovisBCG: sequestration of ATP from macrophage P2Z receptors?”, Molecular Microbiology (1999) 31(5), 1333-1343.
Anomymous: “Plastocyanin precursor” Database EMBL ′Online!, Nov. 1, 1997, XP002306632 abstract.
Anomymous: “Rusticyanin precursor” Database EMBL ′Online!, Mar. 1, 1992, XP002306633 abstract.
Anonymous: “Pseudoazurin precursor” Database EMBL ′Online!, Feb. 1, 1991, XP002306634 abstract.
Vasu Punj et al., “Bacterial Cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer”, Oncogene (2004) 23, 2367-78.
Voet et al., (Biochemistry, 1990, John Wiley & Jons, pp. 415-417, 932 and 933).
Definition of “necrosis” as “to make dead” according to Merriam-Webster Online dictionary downloaded from URL>>www.m-w.com on Apr. 25, 2005.
Goto M. et al., Induction of Apoptosis in Macrophages byPseudomonas aeruginosaAzurin: Tumour-Suppressor Protein p53 and Reactive Oxygen Species, but not Redox Activity, as Critical Elements in Cytotoxticity Molecular Microblbology, 2003, 47 (2): 549-559.
Yamada T. et al., “Rusticyanin, a Bacterial Electron Transfer Protein, causes GL arrest in J774 and apoptosis in Human Cancer Cells. Cell Cycle”, 2004, 3(9):1182-1187.
Punji V. et al., Microbial-Based Therapy of Cancer: a new twist to age old practice. Cancer Biology & Therapy. 2004, 3(8):708-14.
Zaborina, O, et al., Infect. Immun. 67: 5231-5242 (1999).
Melnikov, A. et al., Mol. Microbiol. 36: 1481-1493 (2000).
Punj, V. et al., Infect. Immun. 68: 4930-4937 (2000).
Zaborina, O. et al., Microbiology 146: 2521-2530 (2000).
Kirn, David H. et al., The Journal of Clinical Investigation, vol. 105, No. 7, 837-839 (2000).
Sznol, Mario et al., vol. 105, No. 8, 1027-1030 (2000).
Pawelek, John H, et al., Cancer Research, vol. 57, 4537-4544 (1997).
Potera, Carol, ASM News, vol. 66, No. 6 (2000).
Alexandroff, Anton B. et al., The Lancet, vol. 353, 1689-1694 (May 15, 1999).
O'Donnell, Michael A., Tibtech, vol. 15, 512-517 (Dec. 1997).
Paglia, Paola et al., Cancer Immunol. Immunother., 46:88-92 (1998).
Hunter, Christopher A. et al., The Journal of Immunology, 166: 5878-5881 (2001).
L. H. Dang et al., Proc. Nat. Acad. Sci. USA, 98, 15155-15160 (2001).
R. K. Jain and N. S. Forbes, Proc. Natl. Acad Sci. USA, 98, 14748-14750 (2001).
A. W. Confer and Janet A. Durham, Am. J. Res., vol. 53, No. 5, pp. 646-652 (1992).
T. Wu et al., Antimicrobial Agents and Chemotheraphy, vol. 44, No. 5, pp. 1200-1208 (May 2000).
PCT International Application No. PCT/US02/01408—International Search Report, 2004.
M. Kukimoto et al., FEBS Letters, 394, pp. 87-90 (1996).
F. Cutruzzola et al., J. Inorganic Chemistry, 88, pp. 353-361 (2002).
L. M. Murphy et al., J. Mol. Biol., 315, pp. 859-871 (2002).
V Punj & A. M. Chakrabarty, Cellular Microbiology, 5(4), pp. 225-231 (2003).
T Yamada et al., PNAS, vol. 99, No. 22, pp. 14098-14103 (2002).
T. Yamada et al., Infection & Immunity, vol. 70, No. 12, pp. 7054-7062 (2002).
M. Goto et al., Mol. Bio., 47(2), pp. 549-559 (2003).
V. Punj et al., Biochemical and Biophysical Research Communications, vol. 312, pp. 109-114 (2003).
Vasu Punj et al., Oncogene 2003—Proof copy.
Chakrabarty Ananda M.
Das Gupta Tapas K.
Hiraoka Yoshinori
Punj Vasu
Yamada Tohru
Helms Larry R.
Sheppard Mullin Richter & Hampton LLP
The Board of Trustees of the University of Illinois
Yao Lei
LandOfFree
Cytotoxic factors for modulating cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytotoxic factors for modulating cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic factors for modulating cell death will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112124